Seagen
SGEN
#586
Rank
HK$337.57 B
Marketcap
HK$1,789
Share price
-0.07%
Change (1 day)
69.92%
Change (1 year)

EPS for Seagen (SGEN)

EPS in 2023 (TTM): -HK$31.41

According to Seagen 's latest financial reports the company's current EPS (TTM) is -HK$31.37. In 2022 the company made an earnings per share (EPS) of -HK$25.81 an increase over its 2021 EPS that were of -HK$28.94.

EPS history for Seagen from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$31.4121.68%
2022-HK$25.81-10.81%
2021-HK$28.94-206.32%
2020HK$27.22-458.76%
2019-HK$7.59-31.69%
2018-HK$11.1163.22%
2017-HK$6.81-13%
2016-HK$7.826.38%
2015-HK$7.3551.61%
2014-HK$4.8519.23%
2013-HK$4.0710.64%
2012-HK$3.68-64.66%
2011-HK$10.40101.52%
2010-HK$5.16-27.47%
2009-HK$7.12-15.74%
2008-HK$8.4536.71%
2007-HK$6.185.33%
2006-HK$5.875.63%
2005-HK$5.55-59.89%
2004-HK$13.85139.19%
2003-HK$5.79-3.9%
2002-HK$6.02-24.51%
2001-HK$7.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$10.64-133.92%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$18.71-159.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$85.97-374.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.23-174.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.48-193.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-HK$2.82-91.02%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-HK$2.42-92.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$26.44-15.71%๐Ÿ‡บ๐Ÿ‡ธ USA